Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 529 to 540 of 540 entries
Sorted by: Best Match Show Resources per page
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines.

bioRxiv : the preprint server for biology

Shen X, Tang H, McDanal C, Wagh K, Fischer W, Theiler J, Yoon H, Li D, Haynes BF, Sanders KO, Gnanakaran S, Hengartner N, Pajon R, Smith G, Dubovsky F, Glenn GM, Korber B, Montefiori DC.
PMID: 33532764
bioRxiv. 2021 Jan 29; doi: 10.1101/2021.01.27.428516.

The SARS-CoV-2 Spike glycoprotein mediates virus entry and is a major target for neutralizing antibodies. All current vaccines are based on the ancestral Spike with the goal of generating a protective neutralizing antibody response. Several novel SARS-CoV-2 variants with...

Cite
Shen X, Tang H, McDanal C, et al. SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines. bioRxiv. 2021;doi: 10.1101/2021.01.27.428516.
Shen, X., Tang, H., McDanal, C., Wagh, K., Fischer, W., Theiler, J., Yoon, H., Li, D., Haynes, B. F., Sanders, K. O., Gnanakaran, S., Hengartner, N., Pajon, R., Smith, G., Dubovsky, F., Glenn, G. M., Korber, B., & Montefiori, D. C. (2021). SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.01.27.428516
Shen, Xiaoying, et al. "SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.01.27.428516
Shen X, Tang H, McDanal C, Wagh K, Fischer W, Theiler J, Yoon H, Li D, Haynes BF, Sanders KO, Gnanakaran S, Hengartner N, Pajon R, Smith G, Dubovsky F, Glenn GM, Korber B, Montefiori DC. SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines. bioRxiv. 2021 Jan 29; doi: 10.1101/2021.01.27.428516. PMID: 33532764; PMCID: PMC7852228.
Copy Download .nbib Format: NLM
Worry-related sleep problems and suicidal thoughts and behaviors among adolescents in 88 low-, middle-, and high-income countries: an examination of individual- and country-level factors.

European child & adolescent psychiatry

Kearns JC, Kittel JA, Schlagbaum P, Pigeon WR, Glenn CR.
PMID: 34213638
Eur Child Adolesc Psychiatry. 2021 Jul 02; doi: 10.1007/s00787-021-01838-y. Epub 2021 Jul 02.

A strong association between sleep problems and suicidal thoughts and behaviors (STBs) has been demonstrated in high-income countries. The sleep-STB relationship, however, is minimally understood among youth in low and middle-incomes countries. There also is a limited understanding of...

Cite
Kearns JC, Kittel JA, Schlagbaum P, et al. Worry-related sleep problems and suicidal thoughts and behaviors among adolescents in 88 low-, middle-, and high-income countries: an examination of individual- and country-level factors. Eur Child Adolesc Psychiatry. 2021;doi: 10.1007/s00787-021-01838-y.
Kearns, J. C., Kittel, J. A., Schlagbaum, P., Pigeon, W. R., & Glenn, C. R. (2021). Worry-related sleep problems and suicidal thoughts and behaviors among adolescents in 88 low-, middle-, and high-income countries: an examination of individual- and country-level factors. European child & adolescent psychiatry, . https://doi.org/10.1007/s00787-021-01838-y
Kearns, Jaclyn C, et al. "Worry-related sleep problems and suicidal thoughts and behaviors among adolescents in 88 low-, middle-, and high-income countries: an examination of individual- and country-level factors." European child & adolescent psychiatry vol. (2021). doi: https://doi.org/10.1007/s00787-021-01838-y
Kearns JC, Kittel JA, Schlagbaum P, Pigeon WR, Glenn CR. Worry-related sleep problems and suicidal thoughts and behaviors among adolescents in 88 low-, middle-, and high-income countries: an examination of individual- and country-level factors. Eur Child Adolesc Psychiatry. 2021 Jul 02; doi: 10.1007/s00787-021-01838-y. Epub 2021 Jul 02. PMID: 34213638.
Copy Download .nbib Format: NLM
The mitochondrial genome of the planorbid snail .

Mitochondrial DNA. Part B, Resources

Schultz JH, Bansbach LM, Bremmer JA, Dimmler KE, Forde QA, Gagliano EM, Glenn EM, Greengrass CM, Hayes JP, Kraus AL, Larsen LI, Lucero E, McClendon MT, Mercer HL, Mims KC, Patel KN, Patsalis FI, Peterson DE, Platero JM, Rizvi MM, Serna KI, Steele TE, Turner NL, Bu L, Lu L, Adema CM.
PMID: 33474384
Mitochondrial DNA B Resour. 2018 Oct 30;3(2):972-973. doi: 10.1080/23802359.2018.1503939.

The complete mitochondrial genome of a freshwater planorbid snail,

Cite
Schultz JH, Bansbach LM, Bremmer JA, et al. The mitochondrial genome of the planorbid snail . Mitochondrial DNA B Resour. 2018;3(2):972-973doi: 10.1080/23802359.2018.1503939.
Schultz, J. H., Bansbach, L. M., Bremmer, J. A., Dimmler, K. E., Forde, Q. A., Gagliano, E. M., Glenn, E. M., Greengrass, C. M., Hayes, J. P., Kraus, A. L., Larsen, L. I., Lucero, E., McClendon, M. T., Mercer, H. L., Mims, K. C., Patel, K. N., Patsalis, F. I., Peterson, D. E., Platero, J. M., Rizvi, M. M., Serna, K. I., Steele, T. E., Turner, N. L., Bu, L., Lu, L., & Adema, C. M. (2018). The mitochondrial genome of the planorbid snail . Mitochondrial DNA. Part B, Resources, 3(2), 972-973. https://doi.org/10.1080/23802359.2018.1503939
Schultz, Jonathan H, et al. "The mitochondrial genome of the planorbid snail ." Mitochondrial DNA. Part B, Resources vol. 3,2 (2018): 972-973. doi: https://doi.org/10.1080/23802359.2018.1503939
Schultz JH, Bansbach LM, Bremmer JA, Dimmler KE, Forde QA, Gagliano EM, Glenn EM, Greengrass CM, Hayes JP, Kraus AL, Larsen LI, Lucero E, McClendon MT, Mercer HL, Mims KC, Patel KN, Patsalis FI, Peterson DE, Platero JM, Rizvi MM, Serna KI, Steele TE, Turner NL, Bu L, Lu L, Adema CM. The mitochondrial genome of the planorbid snail . Mitochondrial DNA B Resour. 2018 Oct 30;3(2):972-973. doi: 10.1080/23802359.2018.1503939. PMID: 33474384; PMCID: PMC7800533.
Copy Download .nbib Format: NLM
Late Type 1A Endoleaks: Associated Factors, Prognosis and Management Strategies.

Annals of vascular surgery

O'Donnell TF, McElroy IE, Mohebali J, Boitano LT, Lamuraglia GM, Kwolek CJ, Conrad MF.
PMID: 34752856
Ann Vasc Surg. 2021 Nov 06; doi: 10.1016/j.avsg.2021.08.057. Epub 2021 Nov 06.

BACKGROUND: Unlike periprocedural Type 1A endoleaks, late appearing proximal endoleaks have been poorly described.METHODS: We studied all elective EVAR from 2010 -2018 in a single institution. Late endoleaks were defined as those appearing after 1 year. We used Cox...

Cite
O'Donnell TF, McElroy IE, Mohebali J, et al. Late Type 1A Endoleaks: Associated Factors, Prognosis and Management Strategies. Ann Vasc Surg. 2021;doi: 10.1016/j.avsg.2021.08.057.
O'Donnell, T. F., McElroy, I. E., Mohebali, J., Boitano, L. T., Lamuraglia, G. M., Kwolek, C. J., & Conrad, M. F. (2021). Late Type 1A Endoleaks: Associated Factors, Prognosis and Management Strategies. Annals of vascular surgery, . https://doi.org/10.1016/j.avsg.2021.08.057
O'Donnell, Thomas Fx, et al. "Late Type 1A Endoleaks: Associated Factors, Prognosis and Management Strategies." Annals of vascular surgery vol. (2021). doi: https://doi.org/10.1016/j.avsg.2021.08.057
O'Donnell TF, McElroy IE, Mohebali J, Boitano LT, Lamuraglia GM, Kwolek CJ, Conrad MF. Late Type 1A Endoleaks: Associated Factors, Prognosis and Management Strategies. Ann Vasc Surg. 2021 Nov 06; doi: 10.1016/j.avsg.2021.08.057. Epub 2021 Nov 06. PMID: 34752856.
Copy Download .nbib Format: NLM
A Phase II Cluster-Crossover Randomized Trial of Fentanyl versus Morphine for Analgosedation in Mechanically Ventilated Patients.

American journal of respiratory and critical care medicine

Casamento AJ, Serpa Neto A, Young M, Lawrence M, Taplin C, Eastwood GM, Ghosh A, Bellomo R.
PMID: 34543581
Am J Respir Crit Care Med. 2021 Dec 01;204(11):1286-1294. doi: 10.1164/rccm.202106-1515OC.

No abstract available.

Cite
Casamento AJ, Serpa Neto A, Young M, et al. A Phase II Cluster-Crossover Randomized Trial of Fentanyl versus Morphine for Analgosedation in Mechanically Ventilated Patients. Am J Respir Crit Care Med. 2021;204(11):1286-1294doi: 10.1164/rccm.202106-1515OC.
Casamento, A. J., Serpa Neto, A., Young, M., Lawrence, M., Taplin, C., Eastwood, G. M., Ghosh, A., & Bellomo, R. (2021). A Phase II Cluster-Crossover Randomized Trial of Fentanyl versus Morphine for Analgosedation in Mechanically Ventilated Patients. American journal of respiratory and critical care medicine, 204(11), 1286-1294. https://doi.org/10.1164/rccm.202106-1515OC
Casamento, Andrew J, et al. "A Phase II Cluster-Crossover Randomized Trial of Fentanyl versus Morphine for Analgosedation in Mechanically Ventilated Patients." American journal of respiratory and critical care medicine vol. 204,11 (2021): 1286-1294. doi: https://doi.org/10.1164/rccm.202106-1515OC
Casamento AJ, Serpa Neto A, Young M, Lawrence M, Taplin C, Eastwood GM, Ghosh A, Bellomo R. A Phase II Cluster-Crossover Randomized Trial of Fentanyl versus Morphine for Analgosedation in Mechanically Ventilated Patients. Am J Respir Crit Care Med. 2021 Dec 01;204(11):1286-1294. doi: 10.1164/rccm.202106-1515OC. PMID: 34543581.
Copy Download .nbib Format: NLM
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis.

Clinical kidney journal

Sinha S, Gould LJ, Nigwekar SU, Serena TE, Brandenburg V, Moe SM, Aronoff G, Chatoth DK, Hymes JL, Miller S, Padgett C, Carroll KJ, Perelló J, Gold A, Chertow GM.
PMID: 35035944
Clin Kidney J. 2021 Jul 06;15(1):136-144. doi: 10.1093/ckj/sfab117. eCollection 2022 Jan.

BACKGROUND: Calcific uraemic arteriolopathy (CUA; calciphylaxis) is a rare disease seen predominantly in patients receiving dialysis. Calciphylaxis is characterized by poorly healing or non-healing wounds, and is associated with mortality, substantial morbidity related to infection and typically severe pain....

Cite
Sinha S, Gould LJ, Nigwekar SU, et al. The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clin Kidney J. 2021;15(1):136-144doi: 10.1093/ckj/sfab117.
Sinha, S., Gould, L. J., Nigwekar, S. U., Serena, T. E., Brandenburg, V., Moe, S. M., Aronoff, G., Chatoth, D. K., Hymes, J. L., Miller, S., Padgett, C., Carroll, K. J., Perelló, J., Gold, A., & Chertow, G. M. (2022). The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clinical kidney journal, 15(1), 136-144. https://doi.org/10.1093/ckj/sfab117
Sinha, Smeeta, et al. "The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis." Clinical kidney journal vol. 15,1 (2022): 136-144. doi: https://doi.org/10.1093/ckj/sfab117
Sinha S, Gould LJ, Nigwekar SU, Serena TE, Brandenburg V, Moe SM, Aronoff G, Chatoth DK, Hymes JL, Miller S, Padgett C, Carroll KJ, Perelló J, Gold A, Chertow GM. The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clin Kidney J. 2021 Jul 06;15(1):136-144. doi: 10.1093/ckj/sfab117. eCollection 2022 Jan. PMID: 35035944; PMCID: PMC8757410.
Copy Download .nbib Format: NLM
Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study.

Clinical journal of the American Society of Nephrology : CJASN

Bushinsky DA, Raggi P, Bover J, Ketteler M, Bellasi A, Rodriguez M, Sinha S, Garg R, Perelló J, Gold A, Chertow GM.
PMID: 33835939
Clin J Am Soc Nephrol. 2021 May 08;16(5):736-745. doi: 10.2215/CJN.16931020. Epub 2021 Apr 07.

BACKGROUND AND OBJECTIVES: In the CaLIPSO study, intravenous administration of SNF472 (300 or 600 mg) during hemodialysis significantly attenuated progression of coronary artery and aortic valve calcification. SNF472 selectively inhibits formation of hydroxyapatite, the final step in cardiovascular calcification....

Cite
Bushinsky DA, Raggi P, Bover J, et al. Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study. Clin J Am Soc Nephrol. 2021;16(5):736-745doi: 10.2215/CJN.16931020.
Bushinsky, D. A., Raggi, P., Bover, J., Ketteler, M., Bellasi, A., Rodriguez, M., Sinha, S., Garg, R., Perelló, J., Gold, A., Chertow, G. M. (2021). Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study. Clinical journal of the American Society of Nephrology : CJASN, 16(5), 736-745. https://doi.org/10.2215/CJN.16931020
Bushinsky, David A, et al. "Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study." Clinical journal of the American Society of Nephrology : CJASN vol. 16,5 (2021): 736-745. doi: https://doi.org/10.2215/CJN.16931020
Bushinsky DA, Raggi P, Bover J, Ketteler M, Bellasi A, Rodriguez M, Sinha S, Garg R, Perelló J, Gold A, Chertow GM. Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study. Clin J Am Soc Nephrol. 2021 May 08;16(5):736-745. doi: 10.2215/CJN.16931020. Epub 2021 Apr 07. PMID: 33835939; PMCID: PMC8259477.
Copy Download .nbib Format: NLM
Coronary artery bypass graft surgery outcomes in the United States: Impact of the coronavirus disease 2019 (COVID-19) pandemic.

JTCVS open

Parcha V, Kalra R, Glenn AM, Davies JE, Kuranz S, Arora G, Arora P.
PMID: 33870234
JTCVS Open. 2021 Jun;6:132-143. doi: 10.1016/j.xjon.2021.03.016. Epub 2021 Mar 30.

OBJECTIVE: There has been a substantial decline in patients presenting for emergent and routine cardiovascular care in the United States after the onset of the coronavirus disease 2019 (COVID-19) pandemic. We sought to assess the risk of adverse clinical...

Cite
Parcha V, Kalra R, Glenn AM, et al. Coronary artery bypass graft surgery outcomes in the United States: Impact of the coronavirus disease 2019 (COVID-19) pandemic. JTCVS Open. 2021;6:132-143doi: 10.1016/j.xjon.2021.03.016.
Parcha, V., Kalra, R., Glenn, A. M., Davies, J. E., Kuranz, S., Arora, G., & Arora, P. (2021). Coronary artery bypass graft surgery outcomes in the United States: Impact of the coronavirus disease 2019 (COVID-19) pandemic. JTCVS open, 6132-143. https://doi.org/10.1016/j.xjon.2021.03.016
Parcha, Vibhu, et al. "Coronary artery bypass graft surgery outcomes in the United States: Impact of the coronavirus disease 2019 (COVID-19) pandemic." JTCVS open vol. 6 (2021): 132-143. doi: https://doi.org/10.1016/j.xjon.2021.03.016
Parcha V, Kalra R, Glenn AM, Davies JE, Kuranz S, Arora G, Arora P. Coronary artery bypass graft surgery outcomes in the United States: Impact of the coronavirus disease 2019 (COVID-19) pandemic. JTCVS Open. 2021 Jun;6:132-143. doi: 10.1016/j.xjon.2021.03.016. Epub 2021 Mar 30. PMID: 33870234; PMCID: PMC8007527.
Copy Download .nbib Format: NLM
NephroCheck® Quality Test.

Blood purification

Naorungroj T, Serpa Neto A, Yanase F, Bittar I, Eastwood GM, Bellomo R.
PMID: 33291111
Blood Purif. 2021;50(4):489-491. doi: 10.1159/000511727. Epub 2020 Dec 08.

BACKGROUND: The acute kidney injury (AKI) risk score helps detect moderate and severe AKI in the next 12-24 h. However, inappropriate urine collection may impact its results.AIM: The aim of this study was to evaluate the stability of NephroCheck®...

Cite
Naorungroj T, Serpa Neto A, Yanase F, et al. NephroCheck® Quality Test. Blood Purif. 2020;50(4):489-491doi: 10.1159/000511727.
Naorungroj, T., Serpa Neto, A., Yanase, F., Bittar, I., Eastwood, G. M., & Bellomo, R. (2021). NephroCheck® Quality Test. Blood purification, 50(4), 489-491. https://doi.org/10.1159/000511727
Naorungroj, Thummaporn, et al. "NephroCheck® Quality Test." Blood purification vol. 50,4 (2021): 489-491. doi: https://doi.org/10.1159/000511727
Naorungroj T, Serpa Neto A, Yanase F, Bittar I, Eastwood GM, Bellomo R. NephroCheck® Quality Test. Blood Purif. 2021;50(4):489-491. doi: 10.1159/000511727. Epub 2020 Dec 08. PMID: 33291111.
Copy Download .nbib Format: NLM
Building on the past 50 years, not starting over: A balanced interpretation of meta-analyses, reviews, and commentaries on treatments for suicide and self-injury.

General hospital psychiatry

Kleiman EM, Bentley KH, Glenn CR, Liu RT, Rizvi SL.
PMID: 34800775
Gen Hosp Psychiatry. 2021 Nov 13;74:18-21. doi: 10.1016/j.genhosppsych.2021.11.002. Epub 2021 Nov 13.

No abstract available.

Cite
Kleiman EM, Bentley KH, Glenn CR, et al. Building on the past 50 years, not starting over: A balanced interpretation of meta-analyses, reviews, and commentaries on treatments for suicide and self-injury. Gen Hosp Psychiatry. 2021;74:18-21doi: 10.1016/j.genhosppsych.2021.11.002.
Kleiman, E. M., Bentley, K. H., Glenn, C. R., Liu, R. T., & Rizvi, S. L. (2021). Building on the past 50 years, not starting over: A balanced interpretation of meta-analyses, reviews, and commentaries on treatments for suicide and self-injury. General hospital psychiatry, 7418-21. https://doi.org/10.1016/j.genhosppsych.2021.11.002
Kleiman, Evan M, et al. "Building on the past 50 years, not starting over: A balanced interpretation of meta-analyses, reviews, and commentaries on treatments for suicide and self-injury." General hospital psychiatry vol. 74 (2021): 18-21. doi: https://doi.org/10.1016/j.genhosppsych.2021.11.002
Kleiman EM, Bentley KH, Glenn CR, Liu RT, Rizvi SL. Building on the past 50 years, not starting over: A balanced interpretation of meta-analyses, reviews, and commentaries on treatments for suicide and self-injury. Gen Hosp Psychiatry. 2021 Nov 13;74:18-21. doi: 10.1016/j.genhosppsych.2021.11.002. Epub 2021 Nov 13. PMID: 34800775.
Copy Download .nbib Format: NLM
Application of Engineered Bacteriophage T7 in the Detection of Bacteria in Food Matrices.

Frontiers in microbiology

Wisuthiphaet N, Yang X, Young GM, Nitin N.
PMID: 34421846
Front Microbiol. 2021 Aug 06;12:691003. doi: 10.3389/fmicb.2021.691003. eCollection 2021.

Detection of pathogens in a food matrix is challenging due to various constraints including complexity and the cost of sample preparation for microbial analysis from food samples, time period for the detection of pathogens, and high cost and specialized...

Cite
Wisuthiphaet N, Yang X, Young GM, et al. Application of Engineered Bacteriophage T7 in the Detection of Bacteria in Food Matrices. Front Microbiol. 2021;12:691003doi: 10.3389/fmicb.2021.691003.
Wisuthiphaet, N., Yang, X., Young, G. M., & Nitin, N. (2021). Application of Engineered Bacteriophage T7 in the Detection of Bacteria in Food Matrices. Frontiers in microbiology, 12691003. https://doi.org/10.3389/fmicb.2021.691003
Wisuthiphaet, Nicharee, et al. "Application of Engineered Bacteriophage T7 in the Detection of Bacteria in Food Matrices." Frontiers in microbiology vol. 12 (2021): 691003. doi: https://doi.org/10.3389/fmicb.2021.691003
Wisuthiphaet N, Yang X, Young GM, Nitin N. Application of Engineered Bacteriophage T7 in the Detection of Bacteria in Food Matrices. Front Microbiol. 2021 Aug 06;12:691003. doi: 10.3389/fmicb.2021.691003. eCollection 2021. PMID: 34421846; PMCID: PMC8377434.
Copy Download .nbib Format: NLM
Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial.

Diabetes care

McAuley SA, Trawley S, Vogrin S, Ward GM, Fourlanos S, A Grills C, Lee MH, Alipoor AM, O'Neal DN, O'Regan NA, Sundararajan V, Colman PG, MacIsaac RJ.
PMID: 34844995
Diabetes Care. 2021 Nov 29; doi: 10.2337/dc21-1667. Epub 2021 Nov 29.

OBJECTIVE: To assess the efficacy and safety of closed-loop insulin delivery compared with sensor-augmented pump therapy among older adults with type 1 diabetes.RESEARCH DESIGN AND METHODS: This open-label, randomized (1:1), crossover trial compared 4 months of closed-loop versus sensor-augmented...

Cite
McAuley SA, Trawley S, Vogrin S, et al. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. Diabetes Care. 2021;doi: 10.2337/dc21-1667.
McAuley, S. A., Trawley, S., Vogrin, S., Ward, G. M., Fourlanos, S., A Grills, C., Lee, M. H., Alipoor, A. M., O'Neal, D. N., O'Regan, N. A., Sundararajan, V., Colman, P. G., & MacIsaac, R. J. (2021). Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. Diabetes care, . https://doi.org/10.2337/dc21-1667
McAuley, Sybil A, et al. "Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial." Diabetes care vol. (2021). doi: https://doi.org/10.2337/dc21-1667
McAuley SA, Trawley S, Vogrin S, Ward GM, Fourlanos S, A Grills C, Lee MH, Alipoor AM, O'Neal DN, O'Regan NA, Sundararajan V, Colman PG, MacIsaac RJ. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. Diabetes Care. 2021 Nov 29; doi: 10.2337/dc21-1667. Epub 2021 Nov 29. PMID: 34844995.
Copy Download .nbib Format: NLM
Showing 529 to 540 of 540 entries